← Leaderboards
Pedro Eduardo Almeida Silva
University Of Central Florida
$195,559
Attributed
$586,677
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $147.4K · FY2020–23$200K$150K$100K$50K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$586,677 · 1
By mechanism
R01$586,677 · 1
Top collaborators
- Yulia Gerasimova4 shared
- Kyle H Rohde4 shared
Most similar at University Of Central Florida
Same institution · by research overlap
- Kyle H Rohde$4,255,870
- Yulia Gerasimova$387,106
- Karin Chumbimuni-Torres$680,393
- Herve Roy$1,136,234
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsCystic FibrosisBacteriaBacterial LysateCostCountryBindingBrazilCase StudyCatalytic DnaBacillusChildChronic Disease3d PrintClinically RelevantCohortCo-InfectionCollaborationsColorCommunicable DiseasesComorbidityComplementarity Determining RegionsCessation Of LifeDetection
Grant awards (4)
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.$147,383
R01 · FY2023 · AI
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.$147,383
R01 · FY2022 · AI
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.$146,590
R01 · FY2021 · AI
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.$145,321
R01 · FY2020 · AI